Company profile for ImmuPharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company’s most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing d...
ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company’s most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now completed dosing Lupus patients in its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to peoples lives worldwide.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
ImmuPharma plc 50 Broadway Westminster London SW1H 0RG
Telephone
Telephone
+44 20 7152 4080
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.clinicaltrialsarena.com/news/immupharmas-lupus-trial-second-half/

CLINICAL TRIALS ARENA
20 Jun 2023

https://pharmafile.com/news/immupharma-initiates-phase-2-3-clinical-trial-for-lupus-treatment/

Betsy Goodfellow PHARMAFILE
19 Jun 2023

https://www.proactiveinvestors.co.uk/companies/news/994112/immupharma-says-it-welcomes-helpful-fda-recommendations-ahead-of-phase-iii-study-994112.html

PROACTIVEINVESTORS
30 Sep 2022

https://www.investegate.co.uk/immupharma-plc--imm-/rns/written-response-received-from-the-fda/202209141004114375Z/

INVESTIGATE
14 Sep 2022

https://www.lse.co.uk/news/in-brief-immupharma-raises-gbp950000-from-broker-option-xtqhhq1bk28rezr.html

ISE
11 Aug 2022

https://www.immupharma.co.uk/update-on-p140-lupuzor-clinical-progress-data-confirms-positive-readout-from-p140-pk-study/

PRESS RELEASE
13 Apr 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty